TABLE 2.
tPMP-1 (μg/ml) | Mean ± SD % survival ofa:
|
||||||||
---|---|---|---|---|---|---|---|---|---|
SK982 | SK2355(pSK1) | SK4787(pSK105) | SK2413(pSK107) | SK4027(pSK638) | SK5127(pSK30) | SK2269(pSK78) | NCTC8325 | SK2237(pSK1) | |
12 | 3 ± 1 | 4 ± 1 | 8 ± 1 | 7 ± 2 | 9 ± 3 | 3 ± 1 | 4 ± 2 | 2 ± 0.3 | 7 ± 1 |
6 | 8 ± 1 | 14 ± 2 | 13 ± 2 | 11 ± 2 | 13 ± 1 | 6 ± 0.4 | 10 ± 2 | 5 ± 0.2 | 6 ± 3 |
4 | 19 ± 4 | 25 ± 4 | 24 ± 3 | 24 ± 3 | 26 ± 3 | 7 ± 2 | 16 ± 3 | 7 ± 2 | 33 ± 4 |
3 | 20 ± 3 | 47 ± 3 | 44 ± 3 | 45 ± 3 | 44 ± 4 | 20 ± 3 | 31 ± 4 | 23 ± 4 | 32 ± 4 |
2 | 22 ± 3 | 59 ± 5 | 70 ± 5 | 72 ± 3 | 82 ± 3 | 26 ± 3 | 35 ± 4 | 29 ± 8 | 61 ± 4 |
After 2 h of in vitro exposure under the given conditions. Results represent the mean of three independent experiments.